ArticleCytotherapy2025

Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapy.

Roshini Traynor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.